Busulfan with fludarabine myeloablative conditioning regimen in myeloid neoplasms: A single center experience.

被引：0
|
作者：
Raj, Renju V.
Button, Anna M.
Dozeman, Lindsay
De Magalhaes-Silverman, Margarida
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e18000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18000
引用
收藏
页数：1
相关论文
共 50 条
  • [21] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Sohn, S. K.
    Chae, Y. S.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J. J.
    Kim, Y. K.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S203 - S204
  • [22] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Chae, Y. S.
    Sohn, S. K.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J-J
    Kim, Y-K
    Kim, H-J
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
  • [23] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Y S Chae
    S K Sohn
    J G Kim
    Y Y Cho
    J H Moon
    H J Shin
    J S Chung
    G J Cho
    D H Yang
    J-J Lee
    Y-K Kim
    H-J Kim
    Bone Marrow Transplantation, 2007, 40 : 541 - 547
  • [24] Tolerability and Efficacy of Busulfan and Fludarabine As Allogeneic Pretransplant Conditioning Therapy in Acute Myeloid Leukemia: Comparison With Busulfan and Cyclophosphamide Regimen
    Fedele, Roberta
    Messina, Giuseppe
    Martinello, Tiziana
    Gallo, Giuseppe Alberto
    Pontari, Antonella
    Moscato, Tiziana
    Console, Giuseppe
    Dattola, Antonia
    Princi, Domenica
    Cuzzola, Maria
    Alati, Caterina
    Ronco, Francesca
    Molica, Stefano
    Irrera, Giuseppe
    Martino, Massimo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (06): : 493 - 500
  • [25] Prospective Randomized Comparative Study of Myeloablative Fludarabine/Busulfan (Flu/Bu4) and Fludarabine/Busulfan/Total Body Irradiation (Flu/Bu4/TBI) Conditioning Regimen for Patients with Myeloid Diseases
    Suh, Hyung C.
    Rowley, Scott D.
    Kaur, Sukhdeep
    Lukasik, Brittany
    McKiernan, Phyllis
    Boonstra, Michele
    Baker, Milissa
    Dilorenzo, Mary E.
    Skarbnik, Alan
    Nyirenda, Themba
    Vesole, David H.
    Donato, Michele L.
    BLOOD, 2020, 136
  • [26] FREQUENCY AND IMPACT OF EARLY MIXED CHIMERISM AFTER MYELOABLATIVE CONDITIONING REGIMEN WITH FLUDARABINE AND BUSULFAN (FB4) AND ATG FOR ALLOGENEIC TRANSPLANTATION IN MYELOID MALIGNANCIES
    Grassi, A.
    Pavoni, C.
    Mico, C.
    Finazzi, M. C.
    Lussana, F.
    Taurino, D.
    Rambaldi, A.
    HAEMATOLOGICA, 2019, 104 : 81 - 81
  • [27] Myeloablative conditioning with fludarabine and busulfan for allogeneic PBSCT in chronic phase CML
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Mousavi, A
    Bahar, B
    Jahani, M
    Ghavamzadeh, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 22 - 22
  • [28] A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease
    Khandelwal, Pooja
    Bleesing, Jacob J.
    Davies, Stella M.
    Marsh, Rebecca A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (11) : 2011 - 2018
  • [29] Reduced-intensity conditioning regimen with thiotepa and fludarabine versus busulfan and cyclophosfamicle in myeloid malignancy: a single-centre study
    Alessandrino, E
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Bonfichi, M
    Bragotti, LZ
    Algarotti, A
    Maffioli, M
    Troletti, D
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S196 - S196
  • [30] Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine
    Lee, Je-Hwan
    Joo, Young-Don
    Kim, Hawk
    Ryoo, Hun Mo
    Kim, Min Kyoung
    Lee, Gyeong-Won
    Lee, Jung-Hee
    Lee, Won-Sik
    Park, Jae-Hoo
    Bae, Sung-Hwa
    Hyun, Myung Soo
    Kim, Dae-Young
    Kim, Sung-Doo
    Min, Young Joo
    Lee, Kyoo-Hyung
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 701 - 709
12345